Follow
Murray Barclay
Murray Barclay
Clinical Professor of Medicine, Christchurch Hospital and University of Otago
Verified email at cdhb.health.nz
Title
Cited by
Cited by
Year
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
A Franke, DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, ...
Nature genetics 42 (12), 1118-1125, 2010
31182010
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
CA Anderson, G Boucher, CW Lees, A Franke, M D'Amato, KD Taylor, ...
Nature genetics 43 (3), 246-252, 2011
16872011
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
8202019
Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors
CAM Stedman, ML Barclay
Alimentary pharmacology & therapeutics 14 (8), 963-978, 2000
5122000
Aminoglycosides--50 years on.
EJ Begg, ML Barclay
British journal of clinical pharmacology 39 (6), 597, 1995
4291995
High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study
RB Gearry, A Richardson, CMA Frampton, JA Collett, MJ Burt, ...
Inflammatory bowel diseases 12 (10), 936-943, 2006
3462006
High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis
P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ...
Nature genetics 47 (2), 172-179, 2015
3272015
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
LK Stamp, JL O'Donnell, M Zhang, J James, C Frampton, ML Barclay, ...
Arthritis & Rheumatism 63 (2), 412-421, 2011
3092011
Population‐based cases control study of inflammatory bowel disease risk factors
RB Gearry, AK Richardson, CM Frampton, AJ Dodgshun, ML Barclay
Journal of gastroenterology and hepatology 25 (2), 325-333, 2010
2972010
Azathioprine and 6‐mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
RB Gearry, ML Barclay
Journal of gastroenterology and hepatology 20 (8), 1149-1157, 2005
2862005
consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases
N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ...
Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017
281*2017
Perianal disease predicts changes in Crohn's disease phenotype—results of a population-based study of inflammatory bowel disease phenotype
KM Tarrant, ML Barclay, CMA Frampton, RB Gearry
Official journal of the American College of Gastroenterology| ACG 103 (12 …, 2008
2662008
The spectrum of perianal Crohn’s disease in a population-based cohort
TW Eglinton, ML Barclay, RB Gearry, FA Frizelle
Diseases of the colon & rectum 55 (7), 773-777, 2012
2582012
Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
JM Dalrymple, LK Stamp, JL O'Donnell, PT Chapman, M Zhang, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
2422008
A suggested approach to once‐daily aminoglycoside dosing.
EJ Begg, ML Barclay, SB Duffull
British journal of clinical pharmacology 39 (6), 605-609, 1995
2311995
Population‐based epidemiology study of autoimmune hepatitis: a disease of older women?
JH Ngu, K Bechly, BA Chapman, MJ Burt, ML Barclay, RB Gearry, ...
Journal of gastroenterology and hepatology 25 (10), 1681-1686, 2010
2262010
Reasons for failure to diagnose colorectal carcinoma at colonoscopy
M Leaper, MJ Johnston, M Barclay, BR Dobbs, FA Frizelle
Endoscopy 36 (06), 499-503, 2004
1992004
Submental surface electromyographic measurement and pharyngeal pressures during normal and effortful swallowing
ML Huckabee, SG Butler, M Barclay, S Jit
Archives of physical medicine and rehabilitation 86 (11), 2144-2149, 2005
1752005
The therapeutic monitoring of antimicrobial agents
EJ Begg, ML Barclay, CMJ Kirkpatrick
British Journal of Clinical Pharmacology 52 (S1), 35-43, 2001
1702001
Systematic review with meta‐analysis: SARS‐CoV‐2 stool testing and the potential for faecal‐oral transmission
AS van Doorn, B Meijer, CMA Frampton, ML Barclay, NKH de Boer
Alimentary pharmacology & therapeutics 52 (8), 1276-1288, 2020
1692020
The system can't perform the operation now. Try again later.
Articles 1–20